神经元氧化合成酶的选择性单离子抑制剂. 来自分子动力学模拟的结合模式见解
He Huang1, Haitao Ji, Huiying Li
1Department of Chemistry, Chemistry of Life Processes Institute, amd Center for Molecular Innovation and Drug Discovery, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.
Journal of the American Chemical Society
|June 27, 2012
概括
研究人员设计了神经元氧化合成酶 (nNOS) 的强效,选择性单离子抑制剂,用于治疗神经退行性疾病. 这些新型化合物在保持高疗效的同时提高了生物可用性,标志着治疗开发的重大进展.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 计算化学计算化学
背景情况:
- 抑制神经元氧化合成酶 (nNOS) 为神经退行性疾病提供了治疗潜力.
- 以前的基于pyrrolidine的nNOS抑制剂显示出强度,但由于多个正电荷,其生物利用性较差.
- 一个关键的挑战是降低正电荷,而不会影响抑制剂的强度或选择性.
研究的目的:
- 通过跨学科的方法探索nNOS抑制剂的药理特征.
- 设计具有提高生物可用性的新型,强效和选择性单性nNOS抑制剂.
主要方法:
- 利用分子对接,晶体学和分子动力学模拟来了解连接体-蛋白相互作用.
- 采用合成化学来制造基于pyrrolidine的新型nNOS抑制剂.
- 进行了酶学检测,以评估抑制剂的强度和选择性.
主要成果:
- 确定了关键的稳定因素,包括键,静电和疏水相互作用以及水桥.
- 发现将异质原子纳入连接体的芳香头或连接器可以增强稳定性并阻断基质结合口袋.
- 开发了基于pyrrolidine的新型单性nNOS抑制剂,其中化合物10显示了增强的膜透性.
结论:
- 计算洞察力成功指导了强效和选择性单离子 nNOS 抑制剂的设计.
- 开发的化合物代表了潜在治疗应用的nNOS抑制剂设计的重大进步.
- 整合异原子和优化电荷状态的策略为改善药物的生物可用性提供了一个有希望的途径.
相关概念视频
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...